These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8545524)

  • 1. The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety.
    Walsh DM; Stratton SC; Harvey FJ; Beresford IJ; Hagan RM
    Psychopharmacology (Berl); 1995 Sep; 121(2):186-91. PubMed ID: 8545524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.
    Stratton SC; Beresford IJ; Harvey FJ; Turpin MP; Hagan RM; Tyers MB
    Eur J Pharmacol; 1993 Dec; 250(3):R11-2. PubMed ID: 7906655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents.
    Griebel G; Perrault G; Soubrié P
    Psychopharmacology (Berl); 2001 Nov; 158(3):241-51. PubMed ID: 11713613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models.
    Louis C; Stemmelin J; Boulay D; Bergis O; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2008 Mar; 89(1):36-45. PubMed ID: 18045668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.
    Beresford IJ; Sheldrick RL; Ball DI; Turpin MP; Walsh DM; Hawcock AB; Coleman RA; Hagan RM; Tyers MB
    Eur J Pharmacol; 1995 Jan; 272(2-3):241-8. PubMed ID: 7713168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.
    Micale V; Tamburella A; Leggio GM; Mazzola C; Li Volsi V; Drago F
    Pharmacol Biochem Behav; 2008 Sep; 90(3):463-9. PubMed ID: 18495229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2006 Apr; 83(4):533-9. PubMed ID: 16624395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intra-hippocampal injections of the NK2 receptor antagonist saredutant on the elevated plus maze, and the mouse defense test battery.
    Borelli KG; Defensor EB; Blanchard DC; Blanchard RJ; Griebel G
    Neurosci Lett; 2010 Nov; 485(3):241-5. PubMed ID: 20849917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.
    Costall B; Domeney AM; Kelly ME; Tomkins DM; Naylor RJ; Wong EH; Smith WL; Whiting RL; Eglen RM
    Eur J Pharmacol; 1993 Mar; 234(1):91-9. PubMed ID: 8097165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G; Perrault G; Sanger DJ
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic effects of CCK-B antagonists.
    Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN
    Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function.
    Steinberg R; Alonso R; Griebel G; Bert L; Jung M; Oury-Donat F; Poncelet M; Gueudet C; Desvignes C; Le Fur G; Soubrié P
    J Pharmacol Exp Ther; 2001 Nov; 299(2):449-58. PubMed ID: 11602654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.
    Chizh BA; Cumberbatch MJ; Birch PJ; Headley PM
    Br J Pharmacol; 1995 Jul; 115(6):1013-9. PubMed ID: 7582497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effect of linezolid in experimental mouse models of anxiety.
    Jindal A; Mahesh R; Kumar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():47-53. PubMed ID: 23021974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.